Hidden in Plain Sight
A Patient Guide to the Lymphatic
System and Axillary Surgery Decisions
Medically guided by Lauren Kopicky, DO
Breast Surgical Oncologist, Cleveland Clinic
Medical Advisor, Learn Look Locate
This page is designed as a guided journey—gently pulling back the curtain on a system that often goes unseen.
Step by step, we walk through:
● Why lymph nodes are evaluated
● How axillary surgery has evolved
● And how today’s approach focuses on precision, restraint, and long-term quality of life
You won’t find overwhelming medical language here—just clear, thoughtful guidance to help you understand what’s happening and why.
In Dr. Kopickys words:
“The lymphatic system is the body’s quiet messenger — essential, omnipresent,
and still incompletely understood.”
Guided by Expertise, Designed for Patients
A breast cancer diagnosis usually begins with the breast — imaging, biopsies, surgery.
But just beyond the breast lies a system most patients are never taught to understand.
The lymphatic system works quietly. It moves fluid, supports immune defense, and filters what does not belong. It does not announce itself — yet it plays a powerful role in how breast cancer is staged, and how treatment decisions are made.
“The lymphatic system moves quietly through the body, shaping health and disease while remaining one of medicine’s enduring mysteries.”
The information shared here is medically guided by Dr. Kopicky, whose work in modern axillary management and sentinel lymph node surgery reflects a shift away from routine removal and toward thoughtful decision-making — listening carefully before acting.
Start here.
We’ll walk through it together.
The Map of the Journey
Table of Contents
Table of Contents
(click to scroll back to TOC)
Chapter 1
The Lymphatic System
Quiet. Critical. Hidden in Plain Sight.
Before patients can understand lymph node surgery, they first need to understand what doctors are trying to learn — and why.
The lymphatic system is one of the body’s most essential systems, yet it remains one of the least explained to patients. It works quietly in the background, moving fluid, supporting immune defense, and filtering what does not belong.
Unlike the bloodstream, it does not move fast or announce itself.
As Dr. Lauren Kopicky often shares with patients:
“Hidden in plain sight, the lymphatic system moves quietly through the body,
shaping health and disease while remaining one of medicine’s enduring mysteries.”
For most people, the lymphatic system only becomes visible when breast cancer enters the picture — and when lymph nodes are suddenly discussed with urgency but little context.
This gap between information and understanding is where fear often grows.
This section exists to gently close that gap.
What the lymphatic system actually does
The lymphatic system is a network of:
● Lymphatic vessels
● Lymph nodes
● Lymph fluid
Together, they:
● Collect excess fluid from tissues
● Filter that fluid through lymph nodes
● Support the immune system in recognizing threats
● Return fluid safely to the bloodstream
Lymph nodes are filters and observers. They are not the origin of breast cancer — and they are not inherently dangerous.
How the lymphatic system differs from the bloodstream
Blood flows in a fast, closed loop powered by the heart.
Lymph fluid moves more slowly and without a central pump. Because of this, lymphatic pathways tend to follow predictable routes.
This predictability is what allows surgeons to map lymph drainage from the breast with precision.
Why the lymphatic system matters in breast cancer
Breast tissue drains lymph fluid along consistent pathways. If cancer cells were ever to leave the breast, they would most often travel through these channels first.
This does not mean cancer is expected to spread — only that the lymphatic system can act as an early messenger.
In Dr. Kopicky’s words:
“The lymphatic system is the body’s quiet messenger — essential, omnipresent,
and still incompletely understood.”
By listening to that message carefully, surgeons can make informed decisions while avoiding unnecessary disruption.
Does lymph node involvement always mean worse outcomes?
No.
Modern breast cancer care considers many factors together—including tumor biology, response to treatment, and targeted therapies.
Lymph node findings are just one part of a much larger picture and do not determine outcomes on their own.
The lymphatic system is not something to fear. It is a quiet partner in your body — one that modern breast cancer care has learned how to listen to, rather than disrupt.
Or, as Dr. Kopicky so simply puts it:
“The lymphatic system is critical, quiet, and mysterious.”
Why are lymph nodes part of cancer staging?
Lymph nodes are evaluated to help doctors understand:
● Whether cancer has stayed in the breast
● Whether it has involved nearby lymph nodes
● How best to tailor treatment
Lymph node findings provide information, not a verdict.
Chapter 2
The Axilla
Where Paths Converge
and Decisions Begin.
Every journey through the lymphatic system eventually arrives at a crossroads.
That crossroads is called the axilla—the underarm region where lymphatic pathways from the breast naturally converge.
It is not a danger zone.
It is not a failure point.
It is a meeting place where information gathers.
For many patients, the axilla is introduced suddenly, often wrapped in unfamiliar language and urgency.
This section slows that moment down—because understanding the axilla is key to understanding why modern breast cancer surgery looks very different than it once did.
What the axilla is
The axilla is the area under the arm that contains:
● Lymph nodes
● Lymphatic vessels
● Blood vessels
● Nerves that control arm movement and sensation
Because lymph fluid from the breast drains toward the axilla, this region becomes important in understanding—not assuming—whether cancer has moved beyond the breast.
The axilla is not where cancer begins. It is where information may be found.
Why does breast cancer care focus on the axilla?
Breast tissue drains lymph fluid along predictable pathways. The axilla is where those pathways converge.
By evaluating this area, doctors can:
● Better understand cancer stage
● Tailor treatment decisions
● Avoid unnecessary surgery
● Protect long-term arm and lymphatic function
What “axillary management” means
Axillary management refers to the strategy used to decide:
● How many lymph nodes, if any, should be removed
● Whether surgery, radiation, or observation is most appropriate
Does axillary management always mean surgery?
No.
Modern axillary management may involve:
● No lymph node surgery
● Sentinel lymph node biopsy (removing only the first draining node[s])
● Axillary lymph node dissection (removing more nodes when clearly needed)
● Radiation therapy instead of additional surgery
The goal is to get essential information while preserving function.
Why the axilla requires careful decision-making
The axilla is a delicate region.
Because it contains important nerves and lymphatic vessels, treatment in this area can affect:
● Arm strength and range of motion
● Sensation in the arm or chest wall
● Long-term lymphatic drainage
What happens if too many lymph nodes are removed?
Removing more lymph nodes than necessary can increase the risk of:
● Lymphedema (swelling of the arm or chest)
● Numbness or tingling
● Shoulder stiffness
● Chronic discomfort
The axilla as a crossroads — not a command
In the past, axillary surgery often followed a single rule: remove many lymph nodes “just in case.”
Today, the axilla is treated as a crossroads—a place where surgeons stop, listen, and choose the path that best supports both cancer control and long-term quality of life.
This shift reflects years of research and a deeper understanding of how breast cancer behaves—and how patients live after treatment.
Chapter 3
The Sentinel Lymph Node
The Guardian at the Gate.
Every System Has A First Checkpoint.
In the lymphatic system, that checkpoint is the sentinel lymph node — the first lymph node (or small group of nodes) that lymph fluid from the breast naturally drains into.
The word sentinel means guardian.
That meaning is intentional.
If cancer cells were ever to leave the breast, this is most often the first place they would pass — not because the node attracts cancer, but because it stands at the gate of the natural drainage pathway.
Modern breast surgery begins here.
Rather than opening every gate in the axilla, surgeons pause at the sentinel — listening carefully before deciding whether more surgery is necessary.
Why the sentinel node matters so much
The sentinel node is powerful because it offers clarity—with restraint.
By evaluating this first “guardian,” surgeons can:
● Learn whether cancer has moved beyond the breast
● Avoid removing healthy lymph nodes unnecessarily
● Reduce long-term risks like lymphedema
● Preserve arm strength, sensation, and lymphatic flow
Why not remove all lymph nodes “just to be safe”?
Decades of research have shown that removing more lymph nodes does not improve outcomes for most patients — and it does increase the risk of long-term complications.
The sentinel node allows surgeons to gather the information they need without disrupting the entire system.
More surgery is not better surgery.
Smarter surgery is.
The guardian at the gate — a surgical pause
Think of the sentinel node as a calm, observant guard.
At this gate, the surgeon asks:
● Is the signal quiet?
● Is there evidence that cancer has traveled?
● If so, how much—and does it change the plan?
What does it mean if cancer is found in the sentinel node?
Finding cancer in the sentinel node does not automatically mean:
● Cancer is widespread
● More surgery is required
● Outcomes are worse
Doctors look at the full picture, including
● The amount of cancer present
● Whether it is microscopic (micrometastases) or larger
● Tumor biology (such as hormone receptors and HER2 status)
● Whether systemic therapy is planned or already given
The sentinel node helps guide the next step — it does not dictate it.
How many sentinel nodes are typically removed?
Often, only one to three sentinel nodes are identified and removed.
The goal is not quantity.
The goal is accuracy.
Surgeons follow the body’s natural pathways to locate the correct node or nodes—minimizing disruption while maximizing information.
Can there be more than one sentinel node?
Yes.
Some breasts drain to more than one sentinel node. When this happens, surgeons may evaluate more than one guardian — still far fewer than in older surgical approaches.
From routine removal to thoughtful precision
Sentinel lymph node surgery represents one of the most important advances in breast cancer care.
It reflects a broader shift in how surgeons approach treatment:
● Listen before acting
● Use evidence, not habit
● Protect quality of life alongside cancer control
The sentinel lymph node is not a warning sign.
It is a guardian — quietly holding information that helps your care team choose the safest, most thoughtful path forward.
To find the right gate, surgeons don’t guess.
They map the path — following the body’s own signals using light, tracers, and precision tools.
Chapter 4
Mapping the Sentinel Node
Light, Signal, and Precision
Following the Body’s Path.
Before a surgeon can pause at the sentinel node,
they must first find it.
This is where mapping comes in.
Mapping the sentinel node is the process of following the body’s natural lymphatic drainage—from the breast to the first “guardian” node.
Surgeons do not guess.
They do not rely on routine removal.
They follow the path.
This step transforms lymph node surgery from exploration into precision.
How breast surgeons follow the path
Lymphatic pathways are subtle. They are not visible.
To reveal them, surgeons use tracers—gentle signals that move through the lymphatic system in the same way lymph fluid does. These tracers act like a lantern, illuminating the path that already exists beneath the surface.
The goal is simple:
Identify the first node that receives drainage from the breast.
That node — or small group of nodes — is the sentinel.
Mapping techniques used today
Modern breast surgery may use one or more of the following mapping methods:
Prior to surgery one or more of the tracers may be injected near the tumor or near the nipple.
Each serves the same purpose: accuracy with minimal disruption.
Blue Dye
A blue dye is injected before surgery.
● The dye travels through lymphatic vessels
● The first lymph node it reaches becomes visibly blue
● This helps surgeons visually identify the sentinel node
The dye simply highlights the path your lymph fluid already takes.
Radioactive Tracer
A small amount of radioactive tracer is injected before surgery.
● It travels through lymphatic channels
● A special probe detects the signal during surgery
● The node with the strongest signal is identified as the sentinel node
The radiation exposure is very low and localized. It does not stay in your body.
Indocyanine Green (ICG)
ICG is a fluorescent dye used with near-infrared imaging.
● It glows under special light
● Allows real-time visualization of lymphatic flow
● Helps surgeons clearly see drainage pathways
This technique adds another layer of precision — especially helpful in complex anatomy.
Superparamagnetic Iron Oxide (SPIO)
SPIO uses tiny magnetic particles.
● The particles travel through lymphatic channels
● A magnetic probe identifies the sentinel node
● No radioactive material is involved
This method offers an alternative approach while maintaining accuracy and can be used for delayed mapping.
Why are there different mapping methods?
Different patients, surgical settings, and technologies call for different tools.
What matters most is not which tracer is used, but that mapping:
● Follows the body’s natural drainage
● Identifies the correct sentinel node
● Minimizes unnecessary lymph node removal
Surgeons may use one method or a combination to ensure accuracy.
Why mapping matters so much
Mapping allows surgeons to:
● Identify the right node, not just any node
● Avoid removing unnecessary lymph nodes
● Reduce the risk of long-term complications
● Make informed decisions based on real signals
This is one of the key reasons lymph node surgery today looks very different than it did decades ago.
Does mapping ever fail?
Mapping is highly reliable, but no technique is perfect.
In rare cases:
● Lymphatic pathways may be altered by prior surgery or radiation
● A sentinel node may not be clearly identified
When this happens, surgeons use clinical judgment — always balancing information gained against potential harm.
Mapping is not guesswork.
It is following your body’s design — using light and signal to find the right gate, and only that gate.
Once the path is revealed, the surgeon can pause — and listen carefully at the gate.
That moment is called a Sentinel Lymph Node Biopsy.
This idea can feel surprising — even unsettling — because for decades, lymph node surgery was considered automatic.
Today, research has shown that in certain situations, lymph node surgery does not change treatment decisions or outcomes.
In these cases, leaving the gate closed is not avoidance.
It is evidence-based care.
Chapter 5
Sentinel Lymph
Node Biopsy (SLNB)
Listening Before Acting.
Once the sentinel node has been mapped the surgeon reaches a moment of pause. This moment is called a Sentinel Lymph Node Biopsy, often shortened to SLNB.
Despite the word biopsy, this is not a random sample. It is a targeted, intentional step—removing only the sentinel node(s) so they can be examined closely.
This approach reflects one of the most important shifts in breast cancer surgery:gathering information before taking action.
What a sentinel lymph node biopsy really is
A Sentinel Lymph Node Biopsy involves:
● Removing the sentinel lymph node (or small group of nodes)
● Sending those nodes to pathology
● Carefully examining them for cancer cells
The goal is not removal for removal’s sake.
The goal is understanding.
By listening at the sentinel node, surgeons can decide whether the axilla needs further attention or whether the gate can remain undisturbed.
By listening at the sentinel node, surgeons can decide whether the axilla needs further attention or whether the gate can remain undisturbed.
How is SLNB different from older lymph node surgery?
In the past, surgeons routinely removed many lymph nodes from the axilla, often without knowing whether cancer was present.
SLNB changed that approach by:
● Targeting only the first draining node(s)
● Reducing unnecessary lymph node removal
● Preserving lymphatic and nerve function
● Lowering the risk of long-term side effects
It is a more thoughtful, evidence-based way to learn what matters.
What surgeons are looking for
When the sentinel node is examined, pathologists look for:
● Whether cancer cells are present
● How many cells are present
● Whether the cancer is microscopic or larger
● Patterns that may influence treatment decisions
Not all findings carry the same meaning.
Context matters.
What happens if the sentinel node is clear?
If no cancer is found:
● The gate often stays closed
● No additional lymph node surgery is needed
● The axilla is left largely undisturbed
This outcome allows many patients to avoid further surgery entirely.
What happens if cancer is found?
Finding cancer in the sentinel node does not automatically mean more surgery.
Doctors consider:
● The amount of cancer present
● Whether it is microscopic (micrometastases)
● Tumor biology (such as hormone receptors and HER2)
● Whether additional treatments have been given or are planned
In many cases today, no further lymph node surgery is required, even when cancer is found.
Why SLNB changed breast cancer care
Sentinel lymph node biopsy transformed axillary management by proving that:
● Information matters more than volume
● Precision matters more than routine
● Quality of life matters alongside cancer control
This approach allows surgeons to protect the lymphatic system whenever possible — stepping forward only when the information truly changes care.
A Sentinel Lymph Node Biopsy is not about taking more.
It’s about listening carefully — and stopping when enough has been learned.Sometimes, the message from the sentinel is quiet.
Other times, it signals that another gate must be opened.
That next step is called an Axillary Lymph Node Dissection.
Chapter 6
Axillary Lymph Node
Dissection ( ALND)
When the Second Gate Opens.
Most journeys through the axilla do not require opening every gate.
But sometimes, the message from the sentinel node is clear enough that more information — or more control — is needed.
This next step is called an Axillary Lymph Node Dissection, often shortened to ALND.
It is important to say this gently and clearly:
ALND is not a failure.
It is a purposeful decision, made when the information gathered at the first gate truly changes the path forward.
What is an axillary lymph node dissection?
An ALND involves removing more lymph nodes from the axilla than in a sentinel lymph node biopsy.
This is done when:
● There is a higher burden of cancer in the lymph nodes
● The information from additional nodes will guide treatment
● Local control of disease is needed to reduce recurrence risk
This is not routine.
It is selective.
How is ALND different from SLNB?
SLNB removes only the first draining node(s) to gather information
● ALND removes a larger group of lymph nodes when more intervention is necessary
ALND is used less often today than in the past, because many patients no longer benefit from extensive axillary surgery.
Why ALND is used more carefully today
Historically, ALND was performed routinely — even when cancer had not spread.
Over time, research showed that:
● Removing more nodes did not always improve outcomes
● Many patients experienced long-term side effects
● Less invasive approaches could offer the same cancer control for many people.
As a result, modern breast cancer care uses ALND only when it meaningfully affects treatment decisions or disease control.
What factors influence the decision to perform ALND?
Doctors consider:
● How many sentinel nodes contain cancer
● The amount of cancer in those nodes
● Tumor biology (such as hormone receptors and HER2)
● Whether systemic therapy or radiation is planned
● Overall patient health and goals of care
ALND is never a reflex.
It is a measured choice.
Understanding the trade-offs
Because the axilla contains important lymphatic vessels and nerves, ALND carries higher risks than sentinel node surgery
These can include:
● Increased risk of lymphedema
● Numbness or tingling in the arm or chest
● Shoulder stiffness or reduced range of motion
This is why surgeons today weigh benefit versus impact so carefully before opening the second gate.
Does everyone who needs ALND get lymphedema?
No.
Many people do not develop lymphedema — but the risk is higher after ALND than after SLNB.
This is why preventing unnecessary ALND has become a major focus of modern care.
The second gate — opened with intention
When ALND is recommended, it is because:
● The information matters
● The benefit outweighs the risk
● The decision is grounded in evidence, not habit
Opening the second gate is not about doing more.
It is about doing what is necessary — and no more than that.
Axillary lymph node dissection is not the default path.
It is chosen only when it truly helps guide or protect your care.
As evidence grew, surgeons began asking an important question:
What if fewer gates needed to be opened at all?
Chapter 7
Choosing Restraint
De-escalation of
Axillary Surgery
Keeping the gates closed.
For many years, breast cancer surgery followed a single belief:
more surgery meant more safety.
As evidence accumulated, that belief began to change.
Surgeons started asking a different question — not “How much can we remove?” but “How little can we remove while still protecting patients?”
This shift is called de-escalation of axillary surgery, and it represents one of the most meaningful advances in modern breast cancer care.
What de-escalation means
Why did surgeons start de-escalating axillary surgery?
De-escalation does not mean doing less care.
It means doing only what is necessary — and stopping when further surgery will not improve outcomes.
In the axilla, de-escalation focuses on:
● Avoiding routine removal of many lymph nodes
● Using sentinel node information wisely
● Replacing surgery with radiation when appropriate
● Preserving long-term arm and lymphatic function
This approach reflects a deep respect for both evidence and quality of life.
Large clinical trials showed that for many patients:
● Removing additional lymph nodes did not improve survival
● Cancer control could be achieved with less surgery
● Side effects increased with more extensive node removal
As a result, guidelines began shifting away from routine axillary lymph node dissection.
When the gate stays closed
One of the most important outcomes of de-escalation is this:
Sometimes, no further axillary surgery is needed at all.
If the sentinel node is:
● Clear
● Or contains only minimal disease
● And other treatments are planned
Then opening additional gates may offer no benefit — and real harm.
Modern axillary care allows surgeons to stop confidently, knowing that restraint is supported by evidence.
Does de-escalation mean cancer is being ignored?
No.
De-escalation is grounded in:
● Tumor biology
● Response to therapy
● Radiation planning
● Long-term outcome data
Cancer control remains the priority.
The difference is how that control is achieved.
A shift in philosophy — not just technique
De-escalation represents more than a surgical change.
It reflects a broader evolution in breast cancer care:
● From fear-driven decisions
● To evidence-guided choices
● From routine removal
● To intentional protection
This philosophy is especially important in the axilla, where unnecessary disruption can affect
patients long after treatment ends.
Restraint isn’t about doing less, but about stopping when more isn’t beneficial.
In some cases, lymph node surgery may not be needed.
One of the quiet revolutions in modern breast cancer care is this:
Not every patient needs lymph node surgery.
Why surgeons sometimes choose not to operate on lymph nodes
Lymph node surgery is performed to gather information that guides treatment.
When that information would not change the plan, surgery may offer risk without benefit.
Modern guidelines support omitting axillary surgery when:
● Cancer biology is well understood
● Other treatments already address potential spread
● The risks of surgery outweigh the value of the information gained
● An axillary ultrasound shows normal appearing lymph nodes
This approach reflects the same philosophy that guides de-escalation throughout breast cancer care: do what helps — and no more than that.
What professional guidelines support this approach?
Guidance from leading surgical organizations, including the American Society of Breast Surgeons (ASBrS), outlines situations where axillary surgery may be safely omitted.
These recommendations are grounded in clinical trials, long-term outcome data, and evolving treatment strategies.
Situations where lymph node surgery may be omitted
Older patients with favorable breast cancer biology
For some patients aged 70 and older with:
● Early-stage breast cancer
● No clinical signs of lymph node involvement
● Hormone receptor–positive disease
Lymph node surgery may not change treatment decisions and can be safely omitted.
This approach aligns with national Choosing Wisely recommendations.
Pure DCIS undergoing breast-conserving surgery
Ductal Carcinoma In Situ (DCIS) is a non-invasive condition.
When:
● There is no suspicion of invasive cancer
● Breast-conserving surgery is planned
The risk of lymph node involvement is very low (approximately 1–2%), and lymph node surgery is often unnecessary.
Prophylactic mastectomy
When a breast is removed to reduce future risk, rather than to treat known invasive cancer:
● The likelihood of lymph node involvement is extremely low
● Lymph node surgery is typically not performed
This avoids unnecessary disruption to the lymphatic system.
When nodal information will not change treatment
In some situations — such as advanced age or serious medical conditions — lymph node findings would not alter the recommended treatment plan.
In these cases, surgeons may choose to protect quality of life by avoiding axillary surgery altogether.
Does skipping lymph node surgery mean cancer is being ignored?
No.
Omitting lymph node surgery means:
● The cancer is already well-characterized
● Treatment decisions are guided by tumor biology and imaging
● Surgery would not add meaningful information
Cancer care remains active, intentional, and evidence-based.
Confidence in leaving the gate closed
Choosing not to perform lymph node surgery requires confidence — not just in judgment, but in data.
This decision reflects:
● Decades of research
● Advances in imaging and systemic therapy
● A deeper understanding of breast cancer behavior
It also reflects trust in patients — and respect for how treatment affects life long after surgery.
When the gate stays closed, it is not because something was missed.
It is because opening it would not help — and could cause harm.
Sometimes, the message at the gate is barely audible —
not silent, but quiet.
That quiet message has a name.
Chapter 9
Micrometastases
When the Message Is Quiet.
Sometimes, when the sentinel lymph node is examined, the message it carries is not silent — but it is very quiet.
This finding is called micrometastases.
For patients, this word can land heavily. It contains the word metastases, which often sounds frightening and absolute. Without explanation, it can feel like something big has gone wrong — especially when surgery has already gone well.
In reality, micrometastases describe something small, limited, and carefully defined.
What micrometastases actually mean
Micrometastases are:
● Tiny clusters of cancer cells
● Found only under a microscope
● Typically measuring between 0.2 and 2 millimeters
They are not visible on imaging.
They are not felt during surgery.
They are discovered only through detailed pathology.
This distinction matters — because micrometastases behave differently than larger lymph node involvement.
How are micrometastases different from larger lymph node involvement?
● Micrometastases are very small amounts of cancer cells, often discovered only with specialized staining
● Macrometastases are larger, more established deposits of cancer in lymph nodes
These two findings carry different implications and are treated differently in modern breast cancer care.
Why micrometastases often change less than patients expect
In the past, any cancer found in a lymph node often led to more surgery.
Over time, research showed that micrometastases frequently:
● Do not predict widespread disease
● Do not require axillary lymph node dissection
● Do not worsen outcomes when modern systemic therapies are used
Because of this, many patients with micrometastases do not need additional lymph node surgery.
This is one of the clearest examples of how breast cancer surgery has evolved — from reacting to every finding to listening carefully and responding appropriately.
If cancer cells reached the lymph node, doesn’t that mean they’ll spread?
Not necessarily.
Modern breast cancer treatment includes:
● Systemic therapies that circulate throughout the body
● Targeted treatments based on tumor biology
● Radiation therapy when appropriate
These therapies are designed to address microscopic disease — often making additional
surgery unnecessary.
A patient perspective — putting micrometastases in perspective
For many patients, micrometastases are discovered after surgery, even when the tumor in the breast has been fully removed with clear margins. This can feel confusing and unsettling
As the founder of Learn Look Locate, this is something I understand personally. My breast surgery showed clear margins — the cancer in the breast was fully removed. Yet a very small number of cancer cells were found in my sentinel lymph node. That finding, known as micrometastases, is what moved my diagnosis to Stage 2B.
At the time, I didn’t understand how both things could be true at once — and no one explained that this situation is not uncommon.
What I later learned is this:
Micrometastases do not mean surgery failed.
They do not automatically mean more surgery is needed.
They are part of the information that helps doctors look beyond the breast and plan treatment thoughtfully — using surgery, systemic therapy, and radiation together when appropriate.
Chapter 10
Neoadjuvant Therapy
Clearing the Path Before Surgery.
Sometimes, instead of listening at the gate first, doctors choose to clear the path before surgery even begins.
This approach is called neoadjuvant therapy.
For patients, the word can feel technical or confusing. In simple terms, neoadjuvant therapy means treating the cancer before surgery, rather than after.
This decision is intentional — and often powerful.
What neoadjuvant therapy really means
Neoadjuvant therapy refers to treatments such as:
● Chemotherapy
● Targeted therapy (including HER2-directed treatments)
● Immunotherapy
● Hormone therapy (in select cases)
These treatments are given before surgery to:
● Shrink the tumor in the breast
● Treat cancer cells beyond the breast early
● Assess how the cancer responds to treatment
● Potentially reduce the amount of surgery needed
It is not a delay.
It is a strategy.
Why would treatment come before surgery?
Giving treatment first can:
● Make surgery less extensive
● Reduce the need for axillary lymph node dissection
say this instead:
Understand how cancer responds to treatment ( how sensitive to treatment the cancer is, and if a change or additional treatment is needed after surgery)
For some cancers, neoadjuvant therapy provides critical information that surgery alone cannot.
How neoadjuvant therapy affects lymph node surgery
Neoadjuvant therapy can change what happens in the axilla.
If cancer was suspected or confirmed in lymph nodes before treatment:
● Neoadjuvant therapy may eliminate cancer cells in those nodes
● Sentinel lymph node biopsy after treatment may show no remaining disease
● Additional lymph node surgery may be avoided
This is one of the ways modern care reduces long-term side effects without compromising cancer control.
If lymph nodes were involved before treatment, does that mean surgery is still needed?
Not always.
Doctors consider:
● How well the cancer responded to therapy
● Imaging results after treatment
● Sentinel lymph node findings
● Overall treatment plan
In many cases today, patients who respond well to neoadjuvant therapy can avoid more extensive lymph node surgery.
Neoadjuvant therapy as a signal — not a shortcut
Neoadjuvant therapy is not used to “skip” surgery.
It is used to inform surgery.
By seeing how cancer responds to treatment:
● Doctors learn about tumor biology
● Treatment plans can be refined
● Surgery can be tailored more precisely
This approach treats the cancer with strength while honoring you as a whole person, aiming to ease side effects and help you feel as supported as possible throughout treatment.
Neoadjuvant therapy clears the path before surgery —
so when the surgeon arrives at the gate, the message is clearer and the decision more informed.
Protecting the lymphatic system matters not only during treatment —
but long after treatment ends.
That protection has a name — and it deserves careful attention.
Chapter 11
Lymphedema
Protecting the Garden’s Flow
Long after surgery ends, the lymphatic system continues its quiet work.
When that system is disrupted — by surgery, radiation, or both — fluid can sometimes struggle to move as freely as it once did.
This condition is called lymphedema.
For many patients, lymphedema is something they hear about briefly — or not at all — until symptoms appear.
This chapter exists so that doesn’t happen here.
Understanding lymphedema early empowers patients to recognize changes, reduce risk, and protect their bodies long-term.
What lymphedema is — clearly explained
Lymphedema is swelling caused by a buildup of lymph fluid when normal drainage pathways are altered.
It most commonly affects:
● The arm on the side of breast surgery
● The chest wall
● The breast
● The hand or fingers
Lymphedema can develop
● Soon after surgery
● Months later
● Or even years after treatment
It is not inevitable — and when recognized early, it is highly manageable.
Why does lymph node surgery increase lymphedema risk?
Lymph nodes help move fluid through the lymphatic system. When nodes are removed or damaged:
● Fluid may not drain as efficiently
● Pressure can build
● Swelling may develop over time
The risk is higher after axillary lymph node dissection than after sentinel lymph node
biopsy, which is one of the reasons modern care prioritizes de-escalation.
Recognizing early signs — the quiet signals
Early lymphedema symptoms are often subtle.
These can include:
● A feeling of heaviness or fullness
● Tightness in the arm, hand, or chest
● Rings or sleeves feel snug
● Aching or discomfort without injury
These signals matter.
Early intervention can prevent progression and preserve function.
Is lymphedema always visible?
No.
Lymphedema can begin before visible swelling appears. That’s why awareness and self-monitoring are so important.
Reducing risk — what patients can do
While not all lymphedema can be prevented, risk can often be reduced. Helpful steps may include:
● Gentle movement and range-of-motion exercises
● Skin care to prevent infection
● Avoiding unnecessary trauma to the arm
● Wearing compression when recommended
● Seeking early evaluation if symptoms appear
Patients should always discuss individualized prevention strategies with their care team.
Can lymphedema be treated?
Yes.
Treatment options may include:
● Specialized physical therapy
● Compression garments
● Manual lymphatic drainage
● Exercise programs tailored to lymphatic health
Early treatment is associated with better outcomes.
Why modern surgery focuses on prevention
One of the strongest reasons for sentinel node surgery and de-escalation is lymphedema prevention.
By:
● Removing fewer lymph nodes
● Using targeted techniques
● Replacing surgery with radiation when appropriate
Surgeons can protect the lymphatic system while still treating cancer effectively.
Lymphedema is not something to fear — it is something to understand, watch for, and manage early.
Protecting the garden’s flow helps preserve comfort, movement, and quality of life long after treatment ends.
Understanding the system is powerful.
Hearing from the surgeon who navigates it every day brings that understanding to life.
Chapter 12 Watch & Learn
A Conversation with Lauren Kopicky, DO
After walking through the pathways, gates, and decisions that shape lymph node surgery, there is something patients often need next:
A trusted compassionate voice
This chapter centers on a recorded conversation between Dr. Lauren Kopicky, Breast Surgical Oncologist at Cleveland Clinic and Medical Advisor to Learn Look Locate, and Cynthia Jordan, founder of Learn Look Locate and breast cancer survivor.
It is a conversation designed for patients — not rushed, not overly technical, and focused on the questions people rarely have time to ask during appointments.
What this conversation covers
In this interview, Dr. Kopicky addresses the real-world questions that arise once patients begin to understand how lymph node decisions are made, including:
● Why lymph node surgery has changed so dramatically
● How surgeons decide when to stop — and when to go further
● What patients should know about sentinel nodes, micrometastases, and de-escalation
● How quality of life is weighed alongside cancer control
● What patients can ask their own surgeons to feel more informed and confident
This conversation is not about one right path.
It is about understanding how decisions are made.
Why include a video conversation on this page?
Written information builds understanding.
Hearing a surgeon explain decisions in her own words builds trust.
This conversation allows patients to:
● Hear nuance and reassurance
● Understand reasoning beyond headlines
● Feel less alone in complex decisions
It reflects how Dr. Kopicky approaches care — with clarity, intention, and compassion.
A Shared Goal: Thoughtful, Patient-Centered Care
This interview reflects a shared commitment between Learn Look Locate and Dr. Kopicky:
● To demystify complex decisions
● To reduce fear through understanding
● To honor both evidence and lived experience
● To empower patients to ask better questions
It is an extension of the journey you’ve just walked — now spoken aloud.
Now that you’ve walked the journey — and heard from the guide —it’s time to meet her!
About the Expert
Compassionate Breast Surgical Oncologist,
Blending Advanced Science with Truly Personalized Care
Meet Lauren Kopicky, DO, FACOS, FACS
Medical Advisor for Learn Look Locate
Dr. Lauren Kopicky is a fellowship-trained breast surgical oncologist at Cleveland Clinic who specializes in caring for people with both benign and cancerous breast conditions. She has particular expertise in lymph node surgery, including sentinel lymph node biopsy and axillary lymph node dissection, helping patients understand what these procedures mean for staging, treatment decisions, and long-term side effects.
As an osteopathic physician and educator, Dr. Kopicky is known for her calm, thoughtful way of explaining complex choices so they feel clearer and less overwhelming. She partners closely with each patient and the broader care team to balance strong cancer control with preserving function, comfort, and quality of life whenever possible.
Learn Look Locate is honored to collaborate with Dr. Kopicky as a trusted medical advisor on lymph node surgery and breast cancer care. Her expertise and patient-centered approach align with our mission to provide clear, compassionate education that supports informed, empowered decisions at every step of the breast cancer journey.
Chapter 14 Frequently Asked Questions
The Questions Patients Are Really Asking
This chapter gathers the questions that often surface after patients begin to understand lymph node surgery — when fear has softened into curiosity and clarity.
There are no “small” questions here.
Only honest ones.
What is the difference between the axilla and the lymphatic system?
The lymphatic system is a body-wide network that moves fluid and supports immune defense. The axilla is a specific location — the underarm area — where lymphatic pathways from the breast converge. It’s a crossroads within the larger system, not the system itself.
Does lymph node surgery mean cancer has spread?
No.
Lymph node surgery is performed to gather information, not because spread is assumed.
Many patients who undergo sentinel lymph node biopsy have no cancer in their nodes.
If my sentinel node is clear, am I “in the clear”?
A clear sentinel node is reassuring and often means no further lymph node surgery is needed.
However, breast cancer care is based on the whole picture — including tumor biology and planned treatments — not one result alone.
If cancer is found in the sentinel node, does that mean I’ll need more surgery?
Not necessarily.
Today, many patients with cancer in one or two sentinel nodes do not need axillary lymph node dissection, especially when radiation or systemic therapy is part of the treatment plan.
What is the difference between SLNB and ALND?
● Sentinel Lymph Node Biopsy (SLNB): removes only the first draining node(s) to gather information
● Axillary Lymph Node Dissection (ALND): removes more lymph nodes and is used selectively
SLNB is now standard for most patients because it reduces long-term side effects.
What is de-escalation of axillary surgery?
De-escalation means doing less surgery when evidence shows it does not improve
outcomes.
It reflects modern breast cancer care’s focus on:
● Precision
● Quality of life
● Evidence-based decision-making
What are micrometastases, and should I be worried?
Micrometastases are very small clusters of cancer cells found only under a microscope.
They often do not require additional lymph node surgery and are addressed effectively with mo modern treatments.
Why would treatment happen before surgery (neoadjuvant therapy)?
What is lymphedema, and will I get it?
Lymphedema is swelling caused by changes in lymphatic drainage.
Not everyone develops it. The risk is lower with sentinel node surgery and higher with more extensive node removal.
Early awareness and care make a significant difference.
Can lymph node surgery affect my arm long-term?
It can — which is why modern care focuses on minimizing disruption.
Potential effects include:
● Swelling
● Numbness
● Stiffness
De-escalation and early intervention help protect long-term function.
What questions should I ask my surgeon?
Consider asking:
● How many lymph nodes do you expect to remove?
● What information are you trying to learn from them?
● How might this affect my risk of lymphedema?
● Are there options to reduce surgery if findings are minimal?
You deserve clear answers.
Understanding your options helps you move from fear to partnership.
Good questions lead to better conversations — and better care.
Chapter 15
Resources & Evidence
Foundations
The Research Behind Modern Lymph Node Care
Every chapter of this guide reflects a shift in breast cancer care that did not happen overnight.
The movement toward sentinel lymph node biopsy, de-escalation of axillary surgery, and protecting long-term quality of life is grounded in decades of clinical research, professional consensus, and evolving guidelines.
This chapter shares the key organizations and evidence that inform modern lymph node decision-making — including the principles reflected throughout this page and in Dr. Lauren Kopickyis clinical approach.
Key resources referenced in this guide
● American Society of Breast Surgeons (ASBrS)
Resource Guide on Axillary Management for Patients with In-Situ and Invasive Breast Cancer
● Choosing Wisely
Recommendations on Avoiding Routine Sentinel Lymph Node Biopsy in Select Patients
● CancerNetwork
Updates in Surgical Management of the Axilla
● Landmark Axillary Management Trials & Reviews
Including evidence supporting sentinel lymph node biopsy, omission of ALND in select patients, and de-escalation strategies integrated with radiation and systemic therapy
This page is medically guided by Lauren Kopicky, DO, Breast Surgical Oncologist at
Cleveland Clinic and Medical Advisor to Learn Look Locate,
and reflects current evidence supporting modern, patient-centered axillary care.
Closing Reflection
The lymphatic system may be quiet, critical, and mysterious, but the decisions surrounding it no longer need to be.
With evidence, intention, and expert guidance, patients can move forward with clarity rather than fear.
This content has been medically reviewed by:
Lauren Kopicky, DO, FACOS, FACS
Breast Surgical Oncologist, Medical Advisor for Learn Look Locate
